Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Year-over-year gross profit growth rate
Percentile
P72
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 14.75% |
| Q3 2025 | 157.02% |
| Q2 2025 | -19.67% |
| Q1 2025 | 3.11% |
| Q4 2024 | -74.51% |
| Q3 2024 | 1137.45% |
| Q2 2024 | -112.96% |
| Q1 2024 | -79.35% |
| Q4 2023 | 517.55% |
| Q3 2023 | -24.03% |
| Q2 2023 | -112.99% |
| Q1 2023 | 919.28% |
| Q4 2022 | -174.03% |
| Q3 2022 | 284.08% |
| Q2 2022 | 13.70% |
| Q1 2022 | -197.42% |
| Q4 2021 | 185.52% |
| Q3 2021 | 9.46% |
| Q2 2021 | -14.53% |
| Q1 2021 | -2.50% |
| Q4 2020 | -116.66% |
| Q3 2020 | 12607.28% |
| Q2 2020 | 94.78% |
| Q1 2020 | -266.96% |
| Q4 2019 | 58.51% |
| Q3 2019 | -144.99% |
| Q2 2019 | 205.77% |
| Q1 2019 | -31.72% |
| Q4 2018 | -2.53% |
| Q3 2018 | -4.35% |
| Q2 2018 | -0.15% |
| Q1 2018 | -99.24% |
| Q4 2017 | 62.08% |
| Q3 2017 | -30.38% |
| Q2 2017 | -12.02% |
| Q1 2017 | -21.69% |
| Q4 2016 | -47.99% |
| Q3 2016 | -3.50% |
| Q2 2016 | -73.35% |
| Q1 2016 | 8.90% |